✦ LIBER ✦

PCV17 A COST-UTILITY ANALYSIS OF LOSARTAN VERSUS ATENOLOL IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION

✍ Scribed by AH Anis; H Sun; S Singh; JC Woolcott; B Nosyk

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV4: COST ANALYSIS OF AMLODIPINE VERSUS

✍ E Berliner; P Radensky 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PCV60 COST-MINIMIZATION ANALYSIS OF TREA

✍ PC Stafylas; PA Sarafldis; AN Lasaridis; MD Zouka 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

Lisinopril versus atenolol in the treatm

✍ Louis E. Laplante 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 648 KB

A comparative study of doxazosin versus

✍ Gabriele Giorgi; Jacopo M. Legramante; Guiseppe Fioravanti; Giuseppe Paies; Ales 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 525 KB

PCV54 THE COST-UTILITY OF ALISKIREN IN T

✍ A Lee; SJ Barry; L Leiter; A Nanji; L Annemans; D Tucker; AF Michaliszyn; M Barb 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB

Amlodipine VS losartan in the treatment

✍ R Phillips; R.A Kloner; M Weinberger; R.H Grimm 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 172 KB